| http://www.w3.org/ns/prov#value | - Moreover, safety issues and shortage of such preparations are a growing concern, as reported in literature (Bayry J et al., 2007; Hamrock D, 2006).Human recombinant antibodies that have high affinity for antigens expressed on hCMV envelope and are able to neutralize the infection would represent more appropriate drugs for passive immunization.
|
